Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Michael Demurjian Sells 20,000 Shares

Share on StockTwits

Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the business’s stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $1.64, for a total transaction of $32,800.00. Following the completion of the sale, the insider now owns 25,050,521 shares of the company’s stock, valued at approximately $41,082,854.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Michael Demurjian also recently made the following trade(s):

  • On Monday, January 6th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.47, for a total transaction of $29,400.00.
  • On Monday, December 30th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.07, for a total transaction of $21,400.00.
  • On Monday, December 23rd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $0.97, for a total transaction of $19,400.00.
  • On Monday, December 16th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.05, for a total transaction of $21,000.00.
  • On Monday, December 9th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.08, for a total transaction of $21,600.00.
  • On Monday, December 2nd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.14, for a total transaction of $22,800.00.
  • On Monday, November 25th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.13, for a total transaction of $22,600.00.
  • On Monday, November 18th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.09, for a total transaction of $21,800.00.
  • On Monday, November 11th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.16, for a total transaction of $23,200.00.
  • On Monday, November 4th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.27, for a total transaction of $25,400.00.

NASDAQ TYME opened at $1.74 on Thursday. The firm has a market cap of $195.91 million, a PE ratio of -5.44 and a beta of 0.40. The company has a 50 day moving average price of $1.24 and a 200 day moving average price of $1.26. Tyme Technologies Inc has a 52 week low of $0.92 and a 52 week high of $4.01.

Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings data on Monday, November 4th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.02. Analysts anticipate that Tyme Technologies Inc will post -0.21 EPS for the current year.

Several research firms recently commented on TYME. ValuEngine upgraded shares of Tyme Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd. Zacks Investment Research lowered shares of Tyme Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, January 11th.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Paloma Partners Management Co purchased a new stake in Tyme Technologies during the 2nd quarter worth approximately $238,000. Morgan Stanley grew its position in Tyme Technologies by 187.8% during the 2nd quarter. Morgan Stanley now owns 139,579 shares of the company’s stock worth $170,000 after purchasing an additional 91,081 shares during the last quarter. Perkins Capital Management Inc. grew its position in Tyme Technologies by 77.0% during the 3rd quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock worth $170,000 after purchasing an additional 62,000 shares during the last quarter. Squarepoint Ops LLC purchased a new stake in Tyme Technologies during the 3rd quarter worth approximately $71,000. Finally, Bank of New York Mellon Corp grew its position in Tyme Technologies by 5.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock worth $374,000 after purchasing an additional 17,173 shares during the last quarter. Hedge funds and other institutional investors own 12.93% of the company’s stock.

Tyme Technologies Company Profile

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Recommended Story: Why do earnings reports matter?

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Tyme Technologies Inc  Major Shareholder Michael Demurjian Sells 20,000 Shares
Tyme Technologies Inc Major Shareholder Michael Demurjian Sells 20,000 Shares
Gayn Erickson Sells 20,000 Shares of Aehr Test Systems  Stock
Gayn Erickson Sells 20,000 Shares of Aehr Test Systems Stock
Leonard M. Tannenbaum Sells 6,087 Shares of Oaktree Strategic Income Co.  Stock
Leonard M. Tannenbaum Sells 6,087 Shares of Oaktree Strategic Income Co. Stock
H Eric Bolton, Jr. Sells 285 Shares of Mid-America Apartment Communities Inc  Stock
H Eric Bolton, Jr. Sells 285 Shares of Mid-America Apartment Communities Inc Stock
Mansoor Raza Mirza Sells 2,056 Shares of Karyopharm Therapeutics Inc  Stock
Mansoor Raza Mirza Sells 2,056 Shares of Karyopharm Therapeutics Inc Stock
Theodore B. Young Sells 3,000 Shares of Dorian LPG Ltd  Stock
Theodore B. Young Sells 3,000 Shares of Dorian LPG Ltd Stock


© 2006-2020 Ticker Report